Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02990338
Title Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients (ICARIA-MM)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sanofi
Indications

multiple myeloma

Therapies

Dexamethasone + Isatuximab + Pomalidomide

Dexamethasone + Pomalidomide

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.